Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Fujifilm eyes 40...

    Fujifilm eyes 40 percent market share in radiography vertical

    Written by Ruby Khatun Khatun Published On 2018-02-06T10:00:17+05:30  |  Updated On 6 Feb 2018 10:00 AM IST
    Fujifilm eyes 40 percent market share in radiography vertical

    Mumbai: Backed by new launches, Japanese photography and imaging company Fujifilm has set a target to increase its market share to 40 percent this year in the digital radiography segment, a top company official has said.


    The domestic digital radiography market is around Rs 162 crore annually and the company enjoys around 30 percent of this now.


    "We are trying to increase our share in the digital radiography segment from the present 30 percent. We have a target of touching 40 percent market share this year," Fujifilm India senior vice-president medical division Chandershekhar Sibal told.


    A leading player in the Rs 300-crore computed radiography segment, it has 50 percent market share.


    In the medical equipment space, the company is present in categories such as computed radiography, digital radiography, imagers and dry films, mammography, flat panels, endoscopy, dry chemistry analyser and healthcare IT, and Sibal said they are trying to increase its share in each vertical.


    The total medical equipment industry is estimated to be around USD 1.5 billion in the country.


    The Japanese company, which had clocked a revenue of Rs 1,000 crore here last fiscal year, is expecting a growth of 10 percent this fiscal year.


    Medical healthcare products, which are a growth driver for the firm, forms half of its Rs 1,000 crore turnover, while photo imaging, image capturing, graphic arts, recording, media and industrial products contribute the remaining 50 percent.


    Buoyed by the demand from small towns, it is aiming to clock a 20 percent growth in its medical systems business this fiscal.


    "The healthcare industry is growing by 10 percent. We are expecting a growth of 20 percent this fiscal and also next fiscal.


    "The demand is now coming from small towns and cities and over 50 percent of sales come from these cities," Sibal said, adding they are also actively engaged in various public-private partnership projects which has helped it to reach even the smallest of the villages.


    Last fiscal year, the medical business vertical had posted a growth of only 7 percent, impacted due to demonetisation against a normal growth of 10-12 percent.


    India contributes to around 2 percent of Fujifilm's global revenue, but Sibal said, "there is a lot of focus on this and we are looking at it as a high growth market."

    Chandershekhar Sibalcomputed radiographydigital radiography segmentFujifilmFujifilm IndiaHealthcarehealthcare industrymarket sharemedical equipmentradiography
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok